Kenalog
(Triamcinolone)ApprovedSmall molecule
Triamcinolone is a steroid medication used to reduce inflammation and suppress the immune system, helping treat conditions like allergies, asthma, skin conditions, and joint inflammation.[2] Kenalog is currently approved and in use across 53 indications[4].[1]
Kenalog is one of 585 small molecule programs targeting Diabetic Macular Edema. It is currently in Approved.
53
Indications
80
Total Trials
8
Active Trials
584
Competitors
2
FDA Applications
NDA/BLA/ANDA regulatory filings
Pipeline
Status by Indication[4][1]
Indication
Showing 10 of 53 indications
Competition
Competitive Landscape
143 competitors in Osteoarthritis
#DrugCompanyPhaseTrials
1Kenalog
BBassett Healthcare
Approved
Toradol
RochePreclinical
Cataflam
NovartisPreclinical
Bayer Aspirin
BayerPreclinical
Enbrel
IImmunex
Preclinical
Catapres
Boehringer IngelheimPreclinical
MS Contin
HHikma Pharmaceuticals LLC
Preclinical
Glucophage
EMD SeronoPreclinical
Lunesta
Akero TherapeuticsPreclinical
Precedex
MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Keloid4 trials
Steroid Injection4 trials
Evaluation of the Role of Local Steroid Injection in Treatment of Idiopathic Spasmodic Flat Foot in Adolescent Patients
Unknown status·—·N/A·NCT05381558·20 enrolled
Show 1 more trial
Percutaneous Trigger Finger Release Concomitant Steroid Injection Versus Percutaneous Trigger Finger Release Alone
Completed·—·Phase 3·NCT06288685·38 enrolled
Diabetic Macular Edema4 trials
Osteoarthritis4 trials
Steroid4 trials
51 more indications
Arthritis3 trials
Atopic Dermatitis3 trials
MCI2 trials
Carpal Tunnel Syndrome2 trials
Dexmedetomidine Versus Triamcinolone Treatment of Carpal Tunnel Syndrome
Completed·—·N/A·NCT04961281·60 enrolled
Dexmedetomidine Versus Triamcinolone Treatment in Carpal Tunnel Syndrome
Unknown status·—·N/A·NCT05624866·60 enrolled
Dexamethasone2 trials
Shoulder pain2 trials
Macular Edema2 trials
Vitiligo1 trial
Treatment1 trial
Lateral Epicondylitis1 trial
Bursitis1 trial
Pain1 trial
Use of Intravitreal Triamcinolone and Retrobulbar Chlorpromazine as Alternatives to the Management of Painful Blind Eye
Completed·—·N/A·NCT01404364·36 enrolled
Oral Lichen Planus1 trial
The Effect of Topical Curcumin Versus Topical Corticosteroid on Management of Oral Lichen Planus Patients
Unknown status·—·Phase 1·NCT03877679·40 enrolled
Chronic Rhinosinusitis1 trial
Granulation Tissue1 trial
Silver Nitrate Application and Topical Corticosteroids for Hypergranulation Tissue
Unknown status·—·Phase 4·NCT02398539·50 enrolled
Allergic Rhinitis1 trial
Radiofrequency Ablation1 trial
Local Anesthesia1 trial
Needle-Free Injection of Lidocaine for Local Anesthesia Prior to Trigger Digit Injection
Completed·—·N/A·NCT02084706·60 enrolled
Pregnancy1 trial
Lumbar Disc Herniation1 trial
Actinic Keratosis1 trial
Ultrasound1 trial
Dysphagia1 trial
Oral Submucous Fibrosis1 trial
Comparison of Triamcinolone With Pentoxifylline and Vitamin- E Efficacy in the Treatment of Stage 2 and 3 Oral Submucous Fibrosis
Completed·—·Phase 4·NCT05660694·40 enrolled
ESS1 trial
Total Knee Arthroplasty1 trial
Methylprednisolone1 trial
Hip Osteoarthritis1 trial
Cutaneous T-cell lymphoma1 trial
Knee Osteoarthritis1 trial
Peripheral Nerve Stimulation1 trial
Wound1 trial
Unspecified1 trial
Regulatory
FDA Approval Timeline[5]
Jan 1, 1982
ARISTOCORT
NDA NDA011161
Jan 1, 1982
KENACORT
NDA NDA011283
Sources
References
- [1]
- [2]MedlinePlus Drug Information — Kenalog drug information. U.S. National Library of Medicine, National Institutes of Health.
- [3]
- [4]Open Targets Platform — Drug–disease associations for Triamcinolone. EMBL-EBI & Wellcome Sanger Institute.
- [5]
- [6]
Details
Drug Info
Quick Facts
- Mechanism of Action
- Glucocorticoid Receptor Agonist[3]
- Modality
- Small molecule[3]
- Highest Phase
- Approved[1]
- Company
- BBassett Healthcare